2GS-13573-15589

2 vaccinations 9 coded responses 25 check-ins 9 free-text entries 5 call cases

Sex: Male
Age at first dose: 66+
ZIP prefix: 976 / OR
Registered: 2021-01-12

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-12
Registered in v-safe
2021-01-12
Dose 1 — Pfizer-BioNTech
2021-01-12
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2021-01-13
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-14
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-15
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-16
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-17
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-18
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-19
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-28
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-02-02
Dose 2 — Pfizer-BioNTech
2021-02-02
Survey response — day 0, dose 2
MedDRA: Pre-existing disease — Feeling: Good

Free text: Slt orthostasis, min vertigo

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-03
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-02-04
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-02-05
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-06
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-07
Survey response — days 1–6 daily, dose 2
MedDRA: Eye pruritus — Feeling: Good

Free text: Itchy eyes

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-08
Survey response — days 1–6 daily, dose 2
MedDRA: Eye pruritus — Feeling: Good

Free text: Itchy eyes

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-09
Survey response — day 7, dose 2
MedDRA: Eye pruritus — Feeling: Good

Free text: Itchy eyes-moderate Probably pollen

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-16
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-23
Survey response — day 21, dose 2
MedDRA: Lymphadenopathy, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Symptoms: Marked adenopathy · Healthcare visit (other): CT scan

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-23
Report sent to call center — day 21, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-02
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-09
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-16
Survey response — day 42, dose 2
MedDRA: Lymphadenopathy — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Significant adenopathy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-16
Report sent to call center — day 42, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-05-04
Survey response — 3 months, dose 2
MedDRA: Chemotherapy, Diffuse large B-cell lymphoma, Hospitalisation, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization

Free text: MZL converted to an aggressive double expressing DLBCL 2 weeks after 2nd Pfizer vaccine. MZL is rare and this maybe the Ist case of malignant transformation, but temporal association links it to the vaccine. In hospital on chemo now

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-04
Report sent to call center — 3 months, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-16
Call successful
Reported to VAERS voluntarily prior to GDIT contact
2021-08-03
Survey response — 6 months, dose 2
MedDRA: Condition aggravated, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization

Free text: My MZL had a malignant transformation to DLBCL, double expressing, stage IV 2 weeks after second Covid vaccine. Ive been on aggressive chemo since your last enquiry and feel progressively worse. 3 more mo to go with hope for remission.

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-08-03
Report sent to call center — 6 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-08-12
Call 1 — Left Voicemail
2022-02-02
Survey response — 12 months, dose 2
MedDRA: Chemotherapy, Lymphoma — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization

Free text: I got Lymphoma from the Pfizer Covid vaccine. Now complications of chemo. Please call me (b)(6). I am am academic physician and am researching this unique complication.

MedDRA releases: 2024-11 · check-in free text available
2022-02-02
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Hospitalization · 1 call case(s)
2022-02-04
Call successful
Reported to VAERS voluntarily prior to GDIT contact

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-12	Pfizer-BioNTech
2	2021-02-02	Pfizer-BioNTech

Call center

5 call center cases

5 successful

VAERS report filed, before or during a call: 5

See the call center timeline

Free text

Release 3 — day 0, dose 2

2021-02-02

Systemic reaction (other): Slt orthostasis, min vertigo

Release 3 — days 1–6 daily, dose 2

2021-02-07

Systemic reaction (other): Itchy eyes

2021-02-08

Systemic reaction (other): Itchy eyes

Release 3 — day 7, dose 2

2021-02-09

Systemic reaction (other): Itchy eyes-moderate Probably pollen

Release 4 — day 21, dose 2

2021-02-23

Symptoms: Marked adenopathy

Healthcare visit (other): CT scan

Release 5 — day 42, dose 2

2021-03-16

Symptoms: Significant adenopathy

Release 8 — 3 months, dose 2

2021-05-04

Symptoms: MZL converted to an aggressive double expressing DLBCL 2 weeks after 2nd Pfizer vaccine. MZL is rare and this maybe the Ist case of malignant transformation, but temporal association links it to the vaccine. In hospital on chemo now

Release 9 — 6 months, dose 2

2021-08-03

Symptoms: My MZL had a malignant transformation to DLBCL, double expressing, stage IV 2 weeks after second Covid vaccine. Ive been on aggressive chemo since your last enquiry and feel progressively worse. 3 more mo to go with hope for remission.

Release 11 — 12 months, dose 2

2022-02-02

Symptoms: I got Lymphoma from the Pfizer Covid vaccine. Now complications of chemo. Please call me (b)(6). I am am academic physician and am researching this unique complication.

redacted (b)(6)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Unevaluable event	✓	✓	✓
SD	Chemotherapy	✓	✓	✓
SD	Condition aggravated	✓	·	✓
SD	Diffuse large B-cell lymphoma	✓	✓	✓
SD	Hospitalisation	✓	✓	✓
SD	Lymphadenopathy	✓	✓	✓
SD	Lymphoma	·	·	✓
SD	Pre-existing disease	✓	✓	✓
SRO	Eye pruritus	✓	✓	✓
SRO	Pre-existing disease	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release